United States · FDA National Drug Code directory

Flecainide Acetate

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-2995_7f3745b5-2c12-438a-bbdb-32e1803b73f3
Product NDC
71335-2995
Form
TABLET
Composition / generic term
flecainide acetate
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20220915
Source listing expiry
20271231

Source-listed ingredients

  • FLECAINIDE ACETATE — 50 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET in 1 BOTTLE (71335-2995-1) · 71335-2995-1
  • 60 TABLET in 1 BOTTLE (71335-2995-2) · 71335-2995-2
  • 90 TABLET in 1 BOTTLE (71335-2995-3) · 71335-2995-3
  • 10 TABLET in 1 BOTTLE (71335-2995-4) · 71335-2995-4
  • 180 TABLET in 1 BOTTLE (71335-2995-5) · 71335-2995-5

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →